Door-to-door Covid-19 vaccination in Odisha will begin from November 2 in order to boost the inoculation drive. This information was shared by Odisha Family Welfare Director, Bijay Panigrahi on Monday (Nov 1).
Facebook will also remove any claim that Covid-19 vaccines can kill or seriously harm kids, that they are not effective for children at all, and that anything other than a Covid-19 vaccine can inoculate children against the virus.
For the study, published in The Lancet journal, the team reviewed data from 7,28,321 individuals aged 12 or above who had received the third dose of the BNT162b2 vaccine.
"Covid-19 is "the eighth-highest killer of kids in this age group over the past year,"
Biological E, the Hyderabad-based vaccine maker, expects the rollout of its Covid-19 vaccine 'Corbevax' by the end of November and is looking to supply nearly 10 crore doses on the day of its launch
Founded in 1953, Biological E claims to be the first private sector biological products company in India.
Pharma major Biological E has sought approval from drug regulator Drugs Controller General of India to conduct the phase-3 clinical trial of Covid vaccine Corbevax.
Kartik Aaryan was recently spotted by media outside a hospital in Mumbai after taking his final dose of Covid vaccine.
In Septemeber, the Drugs Controller General of India had granted permission for the conducting Phase 3 bridging trials of Sputnik Light on the Indian population.
WHO & an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin.
This is a swarm of people jostling for COVID19 vaccines. These are visuals from outside Athagarh's Gurudijhatia Primary Health Care Centre in Cuttack.
Re-infections can and have happened, even shortly after recovery. And they will become increasingly common as immunity wanes and new SARS-CoV-2 variants arise.
The next phase of COVID-19 vaccination commenced from March 1 for people over 60 years and those aged 45 and above with specified co-morbid conditions.
Applying a tit-for-tat strategy, India on Friday decided to impose reciprocal Covid-19 restrictions on UK nationals arriving in the country.
There is no difference in antibodies produced by Covaxin and Covishield vaccines against the Covid-19 virus. This information was shared by Odisha Health Services Director Bijay Mohapatra on Monday (Sept 27).
Copyright © 2024 - Odisha Television Limited All Rights Reserved.